Eduarda Rocha Santos

Eduarda Rocha Santos

Auto-generated profile, based on publicly available information

Eduarda Rocha Santos

Centro Universitário de Patos de Minas

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
LFLaize Rodrigues da Fonseca
Laize Rodrigues da Fonseca
BRBarbara Dayane Ribeiro
Barbara Dayane Ribeiro
CSCamila Adriane Almeida Silva
Camila Adriane Almeida Silva
ESEduarda Rocha Santos
Eduarda Rocha Santos
FSFabiana de Souza Silva
Fabiana de Souza Silva
SSSara Claudino dos Santos
Sara Claudino dos Santos
Introdução: O uso abusivo de álcool possui efeito nocivo em diversas fases da vida, gerando transtornos mentais e comportamentais de suma importância. Aliado a isso, há um número exorbitante de indivíduos que ingerem álcool com frequência e podem ou não resultar em um uso abusivo. Diante disso, dados atuais demonstram a elevada mortalidade associada ao uso nocivo de álcool o que gerou muitas dúvidas sobre qual seria o perfil dessa população. Objetivo: identificar os aspectos envolvidos na epidemiologia do uso nocivo de álcool no município de Patos de Minas. Metodologia: O presente trabalho consiste em um estudo epidemiológico descritivo, retrospectivo com abordagem de natureza quantitativa. Foi realizada uma pesquisa de dados no Departamento de Informática do Sistema Único de Saúde (DATASUS), analisando todos os casos de internações por transtornos mentais e comportamentais devido ao uso de álcool no município de Patos de Minas (MG), compreendidos entre o período de 2010 a 2020. Discussão: A parcela mais expressiva da população foram os homens, em idade economicamente ativa. Esse fato evidencia o perfil epidemiológico mais prevalente, mesmo havendo uma relativa subnotificação. Considerações finais: Tendo em vista o perfil epidemiológico mais expressivo, fazem-se necessárias ações educativas em saúde que visem modificar esse painel epidemiológico e mitigando o aumento de casos e possíveis riscos.

20 October 2023 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
MPMaria Thereza de Oliveira Romão Pereira
Maria Thereza de Oliveira Romão Pereira
CBCarla Rocha Bontempo
Carla Rocha Bontempo
ESEduarda Rocha Santos
Eduarda Rocha Santos
UBUlisses Rezende Brandão
Ulisses Rezende Brandão
Depression manifests as a set of symptoms that compromise an individual's quality of life. Due to the lack of success certain treatments in some patients, injections of botulinum toxin in the glabellar region have become a potential alternative to help alleviate symptoms associated with the psychiatric disorder. This is an integrative review on the use of botulinum toxin in the treatment of depression. We conducted a cross-referencing of the descriptors "Botulinum Toxin,"Depression, "Emotions," "Facial Feedback," and "Self-esteem" in the following databases: Scientific Electronic Library Online (Scielo), National Library of Medicine (PubMed MEDLINE), and Google Scholar. The location of BoNT/A facial injections is relevant to the success of depression treatment. Glabellar BoNT injections can reduce symptoms of mild to moderate depression. Botulinum toxin can also influence the proprioception of emotions, according to the facial feedback theory. Adverse effects associated with BoNT are generally mild and transiente. Depressive symptoms tend to resurface after a few months of injections, indicating that BoNT may be more effective when used as complementary therapy. Meta-analysis results demonstrate that BTX-A injections have been effective as an adjuvant treatment in Major Depressive Disorder (MDD). BTX-A presents itself as a highly relevant alternative for the treatment of depression. However, further research is needed to provide a deeper.

17 October 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
ESEduarda Rocha Santos
Eduarda Rocha Santos
HVHeitor Cruvinel Oliveira Vida
Heitor Cruvinel Oliveira Vida
JTJoão Victor Marques Thiago
João Victor Marques Thiago
FMFabiano Henrique Moronte
Fabiano Henrique Moronte
With the objective of demonstrating the factors that act directly and indirectly on the etiology of Bipolar Disorder (BD), using the PICO strategy, were used 24 articles with different views about the origin of BD. Those reveal genetic, biological, and ambiental events that would be able to have influence over the individual independently, but mainly, in conclusion, by interconnecting with one another, having in mind that this disorder has an important heritability, until 80%, which isn't a single factor in itself but the confluence of multiple factors. Late diagnosis is a proven risk factor with numerous consequences, mainly taking longer to receive the right treatment. Nevertheless, many of the studies about genetics still use animal models, and it may cast doubt on the validity of some arguments, making evident the importance of continuous and new broader scientific projects about BD. Regardless, observations collected in human datasets remain reliable, being possible to reveal risk factors, which may activate epigenetic mechanisms related to Bipolar Disorder development.

30 May 2023 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
JTJoão Victor Marques Thiago
João Victor Marques Thiago
ESEduarda Rocha Santos
Eduarda Rocha Santos
HVHeitor Cruvinel Oliveira Vida
Heitor Cruvinel Oliveira Vida
ESEverton Adjar Atadeu da Silva
Everton Adjar Atadeu da Silva
This article sought to analyze existing studies on the use of mindfulness in the treatment of substance use disorder aiming to understand its impacts on substance abuse. The results showed that mindfulness can be an effective tool in the treatment of chemical dependencies, reducing substance use and controlling symptoms such as anxiety and depression. However, the results varied according to the type of substance and the profile of the patients. The studies reviewed indicate that mindfulness can help patients develop greater emotional awareness and reduce reactivity to stress, which can be particularly beneficial for individuals suffering from anxiety disorders or depression. Furthermore, mindfulness can help patients develop greater ability to deal with difficult emotions and to regulate their emotional responses. However, there are some limitations in the reviewed studies. Most studies have short duration and do not assess the long-term impact of mindfulness. Furthermore, few studies have investigated the impact of mindfulness on patients dependent on substances other than alcohol and tobacco. In conclusion, mindfulness seems to be a promising tool in the treatment of chemical dependence. However, more research is needed to assess the long-term effectiveness of mindfulness in patients using different substances and patients with different profiles. This could help to improve the understanding the mechanisms of action of mindfulness in the treatment of chemical dependency and to develop more effective therapeutic approaches.

1 July 2025 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
HVHeitor Cruvinel Oliveira Vida
Heitor Cruvinel Oliveira Vida
BCBernardo Augusto Silveira Correa
Bernardo Augusto Silveira Correa
ESEduarda Rocha Santos
Eduarda Rocha Santos
ASAna Cecília Cardoso de Sousa
Ana Cecília Cardoso de Sousa
Representing one of the most significant pandemics in modern history, the new coronavirus (SARS-CoV-2) and its relationship with ABO blood types, already known for various other diseases and other members of the coronavirus family, are currently under investigation. The objective of the present study is to elucidate how the relationships of resistance and susceptibility to COVID-19 vary according to each ABO blood type. In the methodology, a search was conducted in 4 databases, using the PICO strategy with combinations of descriptors: "Blood Type and COVID" and its relevant variations, such as "ABO blood group COVID-19", "Rh factor SARS-CoV-2", "blood group susceptibility COVID-19", and "blood group severity COVID-19". Initially, 45 studies were found, but after applying exclusion criteria, 19 studies remained for analysis. A significant portion of the authors identified greater susceptibility to infection in individuals with blood type A and greater resistance to the virus in group O. However, the relationships with clinical outcomes are still conflicting. Despite the need for greater contributions from the scientific and medical community, it was possible to draw correlations that characterize group A, especially individuals with Rh-positive blood, as the group at higher risk for complications. This knowledge is important for the proper management of patients and for predicting outcomes in cases of SARS-CoV-2 infection.